lysine has been researched along with Acquired Metabolic Diseases, Brain in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (12.50) | 29.6817 |
2010's | 18 (56.25) | 24.3611 |
2020's | 10 (31.25) | 2.80 |
Authors | Studies |
---|---|
Barbieri Caus, L; Calcagnotto, ME; Pasquetti, MV; Seminotti, B; Wajner, M; Woontner, M | 1 |
Crawford, D; Feng, Y; Jackson, M; Khateb, A; Ma, CT; Murad, R; Olson, SH; Pathria, G; Ronai, ZA; Ruppin, E; Scott, D; Sergienko, E; Verma, S | 1 |
Chen, PJ; DeVita, RJ; Dodatko, T; Houten, SM; Khamrui, S; Lazarus, MB; Leandro, J; Sanchez, R; Secor, C; Suebsuwong, C; Yu, C | 1 |
Ballhausen, D; Baumgartner, MR; Beblo, S; Boy, N; Burgard, P; Chapman, KA; Dobbelaere, D; Fleissner, S; Grohmann-Held, K; Hahn, G; Harting, I; Heringer-Seifert, J; Hoffmann, GF; Jochum, F; Karall, D; Kölker, S; Konstantopoulous, V; Krawinkel, MB; Lindner, M; Maier, EM; Märtner, EMC; Mühlhausen, C; Nuoffer, JM; Okun, JG; Plecko, B; Posset, R; Sahm, K; Scholl-Bürgi, S; Thimm, E; Vom Dahl, S; Walter, M; Williams, M; Ziagaki, A; Zschocke, J | 1 |
Chang, FM | 1 |
Bouchereau, J; Schiff, M | 1 |
Beiler, K; Bowser, LE; Brigatti, KW; Carson, VJ; Chopko, S; Haas-Givler, B; Hailey, J; Hendrickson, C; Miller, F; Morton, DH; Poskitt, L; Puffenberger, EG; Robinson, DL; Strauss, KA; Taylor, CM; Williams, KB; Young, M | 1 |
Bernstein, L; Coughlin, CR; Drumm, M; Rohr, F; Yannicelli, S | 1 |
Ballhausen, D; Barroso, M; Braissant, O; Caterino, M; Costanzo, M; Cudalbu, C; Cudré-Cung, HP; Feichtinger, RG; Gersting, SW; Gonzalez Melo, M; Häberle, J; Mayr, JA; Poms, M; Remacle, N; Roux, C; Rüfenacht, V; Ruoppolo, M | 1 |
Baldo, G; Coitinho, AS; de Lima Rosa, G; Faverzani, J; Gome Dos Reis, B; Gonzalez, EA; Guerreiro, G; Moura, AP; Sitta, A; Vargas, CR; Volfart, V; Wajner, M | 1 |
Gao, JZ; Luo, XP; Yi, Q; Ying, YQ; Zhang, C | 1 |
Amaral, AU; da Silva, JC; de Oliveira, FH; Leipnitz, G; Ribeiro, RT; Santamaría, A; Seminotti, B; Souza, DO; Vargas, CR; Wajner, M | 1 |
Ballhausen, D; Braissant, O; Cudré-Cung, HP; do Vale-Pereira, S; Gonzalez, M; Henry, H; Ivanisevic, J; Mühlhausen, C; Remacle, N; Schmiesing, J | 1 |
Amaral, AU; Deon, M; Faverzani, J; Groehs, AC; Guerreiro, G; Ribeiro, RT; Sitta, A; Vargas, CR; Wajner, M | 1 |
Fu, X; Gao, J; Luo, X; Ning, Q; Tian, F; Yi, Q; Zhang, C | 1 |
de Carvalho, TG; de Souza, DO; Goodman, SI; Koeller, DM; Lagranha, VL; Matte, U; Pereira, CC; Seminotti, B; Wajner, M; Woontner, M | 1 |
Amaral, AU; da Rosa, MS; Goodman, S; Koeller, DM; Leipnitz, G; Pereira, CC; Ribeiro, RT; Seminotti, B; Wajner, M; Woontner, M | 1 |
Hoffmann, GF; Kölker, S; Mohr, H; Okun, JG; Opp, S; Posset, R; Sauer, SW; Struys, EA; Völkl, A | 1 |
Blank, AE; Burgard, P; Koeller, DM; Kölker, S; Komatsuzaki, S; Mittelbronn, M; Okun, JG; Opp, S; Sauer, SW | 1 |
Amaral, AU; Cecatto, C; de Oliveira, FH; de Souza, DG; Goodman, S; Lagranha, VL; Pereira, CC; Ribeiro, CA; Seminotti, B; Wajner, M; Woontner, M | 1 |
Assmann, B; Boy, N; Burgard, P; Dixon, M; Fleissner, S; Greenberg, CR; Harting, I; Heringer, J; Hoffmann, GF; Karall, D; Koeller, DM; Kölker, S; Krawinkel, MB; Maier, EM; Mühlhausen, C; Okun, JG; Opladen, T; Posset, R; Sahm, K; Zschocke, J | 1 |
Amaral, AU; da Silva, Lde B; Fernandes, CG; Leipnitz, G; Seminotti, B; Tonin, AM; Vargas, CR; Wajner, M | 1 |
Hoffmann, GF; Koeller, DM; Kölker, S; Okun, JG; Opp, S; Sauer, SW | 1 |
Boy, SP; Burgard, P; Ensenauer, R; Greenberg, CR; Haege, G; Heringer, J; Hoffmann, GF; Koeller, DM; Kölker, S; Maier, EM; Mühlhausen, C; Müller, E; Schlune, A | 1 |
Amaral, AU; Braga, LM; Busanello, EN; Cecatto, C; de Souza, DO; Fernandes, CG; Goodman, S; Koeller, DM; Ribeiro, CA; Seminotti, B; Wajner, M; Woontner, M; Zanatta, Â | 1 |
Botto, LD; Ernst, SL; Longo, N; Pasquali, M; Vanzo, RJ; Viau, K | 1 |
Ashmore, C; Chakrapani, A; Daly, A; Gokmen-Ozel, H; Hendriksz, C; MacDonald, A; Preece, MA; Vijay, S | 1 |
Assmann, B; Boy, N; Burgard, P; Ensenauer, R; Haege, G; Heringer, J; Hoffmann, GF; Kölker, S; Lücke, T; Maier, EM; Mühlhausen, C; Müller, E | 1 |
Gao, JZ; Luo, XP | 1 |
Hasegawa, Y; Kimura, M; Komai, K; Samuraki, M; Terada, N; Yamada, M; Yamaguchi, S | 1 |
Khan, RA; Periasamy, V; Rudwan, M; Yadav, G | 1 |
Prats Viñas, J | 1 |
4 review(s) available for lysine and Acquired Metabolic Diseases, Brain
Article | Year |
---|---|
Update current understanding of neurometabolic disorders related to lysine metabolism.
Topics: Brain Diseases, Metabolic; Epilepsy; Humans; Lysine | 2023 |
Inherited Disorders of Lysine Metabolism: A Review.
Topics: 2-Aminoadipic Acid; Aldehyde Dehydrogenase; Amino Acid Metabolism, Inborn Errors; Arginine; Brain; Brain Diseases, Metabolic; Brain Diseases, Metabolic, Inborn; Carnitine; Epilepsy; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Metabolic Diseases; Pyridoxal Phosphate; Pyridoxine | 2020 |
Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Dietary Supplements; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Lysine | 2017 |
[Progress of glutaric aciduria type I].
Topics: Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases, Metabolic; Child, Preschool; Diagnosis, Differential; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Infant; Infant, Newborn; Lysine; Magnetic Resonance Imaging; Multiple Acyl Coenzyme A Dehydrogenase Deficiency; Mutation; Neonatal Screening; Radiography | 2012 |
1 trial(s) available for lysine and Acquired Metabolic Diseases, Brain
Article | Year |
---|---|
Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.
Topics: Amino Acid Metabolism, Inborn Errors; Anthropometry; Biomarkers; Body Weights and Measures; Brain Diseases, Metabolic; Carnitine; Child; Child, Preschool; Dietary Supplements; Eating; Female; Follow-Up Studies; Food, Formulated; Glutaryl-CoA Dehydrogenase; Humans; Infant; Lysine; Male; Monitoring, Physiologic | 2013 |
27 other study(ies) available for lysine and Acquired Metabolic Diseases, Brain
Article | Year |
---|---|
Increased susceptibility to quinolinic acid-induced seizures and long-term changes in brain oscillations in an animal model of glutaric acidemia type I.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain; Brain Diseases, Metabolic; Disease Models, Animal; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Mice; Mice, Knockout; Quinolinic Acid; Seizures | 2022 |
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; DNA; Glutaryl-CoA Dehydrogenase; Humans; Ketoglutarate Dehydrogenase Complex; Lysine; Melanoma; Mitochondrial Proteins; NF-E2-Related Factor 2 | 2022 |
Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Cysteine; Ethylmaleimide; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Mice; Saccharopine Dehydrogenases | 2022 |
Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision.
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Lysine | 2023 |
Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
Topics: Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases, Metabolic; Carnitine; Child; Child, Preschool; Corpus Striatum; Diet; Female; Glutaryl-CoA Dehydrogenase; Humans; Infant; Infant, Newborn; Lysine; Male | 2020 |
Inconsistencies in the Nutrition Management of Glutaric Aciduria Type 1: An International Survey.
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Child; Child Nutritional Physiological Phenomena; Child, Preschool; Diet Therapy; Dietary Proteins; Female; Glutaryl-CoA Dehydrogenase; Humans; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lysine; Male; Practice Guidelines as Topic; Recommended Dietary Allowances; Surveys and Questionnaires; Tryptophan | 2020 |
The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Arginine; Brain; Brain Diseases, Metabolic; Creatine; Disease Models, Animal; Gene Knock-In Techniques; Gliosis; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Metabolism, Inborn Errors; Rats | 2021 |
Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Carnitine; Cathepsin D; Corpus Striatum; Glutaryl-CoA Dehydrogenase; Grooming; Inflammation; Interleukin-1beta; Locomotion; Lysine; Mice, Knockout; Neuroprotective Agents; Open Field Test; Transforming Growth Factor beta | 2021 |
[Effect of glutaryl-CoA dehydrogenase gene silencing and high-concentration lysine on the viability of BRL hepatocytes].
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Apoptosis; Brain Diseases, Metabolic; Caspase 3; Cell Survival; Cells, Cultured; Fluorescent Antibody Technique; Gene Silencing; Glutaryl-CoA Dehydrogenase; Hepatocytes; Lysine; Rats | 2017 |
Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; CD3 Complex; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutaryl-CoA Dehydrogenase; Inflammation; Lysine; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidation-Reduction; Quinolinic Acid; S100 Calcium Binding Protein beta Subunit; Statistics, Nonparametric; Time Factors; Tyrosine | 2018 |
Ammonium accumulation and chemokine decrease in culture media of Gcdh
Topics: Amino Acid Metabolism, Inborn Errors; Ammonium Compounds; Animals; Brain; Brain Diseases, Metabolic; Cell Culture Techniques; Chemokines; Culture Media; Glutaryl-CoA Dehydrogenase; Lysine; Mice; Mice, Inbred C57BL; Mice, Knockout; Tissue Scaffolds | 2019 |
l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Carnitine; Corpus Striatum; Diet; Disease Models, Animal; Glutaryl-CoA Dehydrogenase; Glutathione Peroxidase; Lysine; Mice; Mice, Knockout; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase | 2019 |
Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Apoptosis; Base Sequence; Biological Transport; Brain Diseases, Metabolic; Caspase Inhibitors; Cell Survival; Gene Expression Regulation; Gene Knockdown Techniques; Glutaryl-CoA Dehydrogenase; Lentivirus; Lysine; Membrane Potential, Mitochondrial; Neostriatum; Neurons; Rats; Rats, Sprague-Dawley; RNA, Small Interfering | 2013 |
Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acid Transport System X-AG; Animals; Brain Diseases, Metabolic; Cerebral Cortex; Diet; Female; Gene Expression Regulation; Glutaryl-CoA Dehydrogenase; Lysine; Male; Mice; Neostriatum; Receptors, Glutamate; RNA, Messenger | 2014 |
Acute lysine overload provokes protein oxidative damage and reduction of antioxidant defenses in the brain of infant glutaryl-CoA dehydrogenase deficient mice: a role for oxidative stress in GA I neuropathology.
Topics: Amino Acid Metabolism, Inborn Errors; Analysis of Variance; Animals; Animals, Newborn; Brain; Brain Diseases, Metabolic; Brain Injuries; Catalase; Disease Models, Animal; Glutaryl-CoA Dehydrogenase; Glutathione; Glutathione Peroxidase; Lysine; Mice; Mice, Transgenic; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase | 2014 |
Understanding cerebral L-lysine metabolism: the role of L-pipecolate metabolism in Gcdh-deficient mice as a model for glutaric aciduria type I.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain; Brain Diseases, Metabolic; Deamination; Disease Models, Animal; Genetic Predisposition to Disease; Glutaryl-CoA Dehydrogenase; Liver; Lysine; Mice, Knockout; Oxidation-Reduction; Oxidoreductases Acting on CH-NH Group Donors; Peroxisomes; Phenotype; Pipecolic Acids | 2015 |
Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
Topics: Aconitate Hydratase; Amino Acid Metabolism, Inborn Errors; Animals; Brain; Brain Diseases, Metabolic; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabolism; Female; Genetic Predisposition to Disease; Glutarates; Glutaryl-CoA Dehydrogenase; Glyceraldehyde-3-Phosphate Dehydrogenases; Ketoglutarate Dehydrogenase Complex; Lysine; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Risk Factors; Sex Factors; Spectrophotometry | 2015 |
Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases; Brain Diseases, Metabolic; Cerebral Cortex; Corpus Striatum; Diet; Disease Models, Animal; Energy Metabolism; Glutaryl-CoA Dehydrogenase; Isocitrate Dehydrogenase; Lactic Acid; Lysine; Membrane Potential, Mitochondrial; Mice, 129 Strain; Mice, Knockout; Oxygen Consumption | 2015 |
Lysine induces lipid and protein damage and decreases reduced glutathione concentrations in brain of young rats.
Topics: Animals; Animals, Newborn; Antioxidants; Brain Diseases, Metabolic; Cerebral Cortex; Down-Regulation; Free Radical Scavengers; Glutathione; Iron Carbonyl Compounds; Lipid Peroxidation; Lysine; Nerve Degeneration; Nerve Tissue Proteins; Neurotoxins; Oxidants; Oxidative Stress; Rats; Rats, Wistar; Sulfhydryl Compounds | 2008 |
Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
Topics: 2-Aminoadipate Transaminase; 2-Aminoadipic Acid; Amino Acid Metabolism, Inborn Errors; Analysis of Variance; Animals; Arginine; Brain; Brain Diseases, Metabolic; Carnitine; Catalase; Glutaryl-CoA Dehydrogenase; Ketoglutaric Acids; Lysine; Mice | 2011 |
Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
Topics: Amino Acid Metabolism, Inborn Errors; Arginine; Brain; Brain Diseases, Metabolic; Child; Child, Preschool; Dietary Supplements; Female; Glutaryl-CoA Dehydrogenase; Humans; Infant; Lysine; Male; Treatment Outcome | 2012 |
Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain; Brain Diseases, Metabolic; Creatine Kinase; Disease Models, Animal; Electron Transport; Glutaryl-CoA Dehydrogenase; Heart; Ketoglutarate Dehydrogenase Complex; Lysine; Mice; Mice, Knockout; Muscle, Skeletal; Myocardium; Sodium-Potassium-Exchanging ATPase | 2012 |
Glutaric acidemia type 1: outcomes before and after expanded newborn screening.
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Child; Child, Preschool; Demography; Female; Glutaryl-CoA Dehydrogenase; Humans; Infant; Infant, Newborn; Lysine; Magnetic Resonance Imaging; Male; Neonatal Screening; Nutritional Status; Young Adult | 2012 |
Dietary practices in glutaric aciduria type 1 over 16 years.
Topics: Adolescent; Adult; Age Factors; Amino Acid Metabolism, Inborn Errors; Biomarkers; Brain Diseases; Brain Diseases, Metabolic; Carnitine; Child; Child, Preschool; Diet, Protein-Restricted; Dietary Proteins; Dietetics; Disabled Persons; Early Diagnosis; Enteral Nutrition; Female; Glucose; Glutaryl-CoA Dehydrogenase; Humans; Lysine; Male; Practice Patterns, Physicians'; Severity of Illness Index; Tryptophan; United Kingdom; Young Adult | 2012 |
A successfully treated adult patient with L-2-hydroxyglutaric aciduria.
Topics: Adult; Age Factors; Alcohol Oxidoreductases; Brain; Brain Diseases, Metabolic; Brain Diseases, Metabolic, Inborn; Carnitine; Chromosomes, Human, Pair 14; Female; Flavin-Adenine Dinucleotide; Genetic Markers; Genetic Predisposition to Disease; Homozygote; Humans; Intellectual Disability; Lysine; Magnetic Resonance Imaging; Movement Disorders; Treatment Outcome | 2008 |
Epilepsy in a young adult caused by L-2-hydroxyglutaric aciduria: a case report.
Topics: Adult; Alcohol Oxidoreductases; Anticonvulsants; Biomarkers; Brain Diseases, Metabolic; Cerebrospinal Fluid; Diagnosis, Differential; Electroencephalography; Epilepsy, Tonic-Clonic; Gas Chromatography-Mass Spectrometry; Humans; Lysine; Magnetic Resonance Imaging; Male; Psychological Tests; Psychometrics; Risk Factors | 2008 |
[Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Carnitine; Child, Preschool; Glutarates; Glutaryl-CoA Dehydrogenase; Humans; Infant; Lysine; Movement Disorders; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Phenotype; Tryptophan | 2001 |